A significant breakthrough in cancer investigation is occurring with the use of mini-antibodies to reactivate damaged p53. This vital malignant inhibitor protein is frequently disabled in several types of cancer, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research